New Research Reveals Biological Roots of Chronic Fatigue Syndrome

Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), is a complex condition marked by extreme tiredness, cognitive problems, and a severe reaction to exertion. For years, its lack of a clear diagnostic marker and overlapping symptoms with depression led to misunderstandings about its causes. The defining feature of ME/CFS is post-exertional malaise (PEM), where even minor physical or mental activity triggers a long-lasting worsening of symptoms. Studies now show that PEM may stem from issues in mitochondrial function, which disrupt the body’s ability to produce energy at a cellular level.

Recent large-scale research has uncovered consistent biological irregularities in patients. These include immune system dysfunction, problems with mitochondria, and changes in the autonomic nervous system. Such findings challenge older assumptions that the illness was purely psychological.

Genetics also play a role in ME/CFS susceptibility. Variants in genes linked to the immune system, as well as NR3C1, NPAS2, and BDNF/COMT, affect how well the body copes with biological stress. These same genetic factors appear across a broader spectrum of chronic fatigue, suggesting the condition exists on a continuum.

Not all patients follow the same biological path to developing ME/CFS. This variability means treatments may need to be tailored to individual cases. Genetic data can help by pointing to which bodily systems are most affected and which treatments might work best. The discovery of biological markers and genetic influences marks a shift in understanding ME/CFS. These advances could lead to more accurate diagnoses and personalised treatments. Researchers now see the condition as a multi-system disorder rather than a psychological one.